Chemours Company (The) vs Linde plc — Stock Comparison
Q·Score Breakdown
4
Bearish
Overall
7.2
Bullish
Quality
Health
Growth
Valuation
Sentiment
CC
56% of 9 covering analysts have a positive rating.
⚠ currently unprofitable (-7% margin).
LIN
High-quality business with 18% return on equity and 20% profit margins.
⚠ valuation metrics above sector average.
Analyst Consensus
BUY
Target $22.67 (-18.3%)
9 analysts
BUY
Target $526.89 (+3.7%)
25 analysts
Fundamentals
CC
LIN
—
Trailing P/E
33.7×
12.1×
Forward P/E
25.8×
-6.6%
Profit Margin
20.4%
15.7%
Gross Margin
48.8%
-93.8%
ROE
18.2%
-2.1%
Revenue Growth
8.2%
—
Earnings Growth
13.4%
1.40
Beta
0.79
—
Price / Book
—
$4.2B
Market Cap
$234.8B
$9 – $28
52-Week Range
$388 – $521
Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →